Flowr Corp
XTSX:FLWR
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
N/A
N/A
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CAD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| CA |
|
Flowr Corp
XTSX:FLWR
|
1.3B CAD |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1T USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
530.8B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
279.4B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
214.1B GBP |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
224.2B CHF |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.8T DKK |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
267.6B USD |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
147.1B USD |
Loading...
|
|
| FR |
|
Sanofi SA
PAR:SAN
|
96.7B EUR |
Loading...
|
Market Distribution
| Min | -4 710 029.9% |
| 30th Percentile | -65.8% |
| Median | -2.4% |
| 70th Percentile | 11% |
| Max | 71 100% |
Other Profitability Ratios
Flowr Corp
Glance View
The Flowr Corp. engages in the production and sale of premium cannabis. The company is headquartered in Toronto, Ontario and currently employs 186 full-time employees. The company went IPO on 2017-09-15. The principal activity of the Company is the production and sale of cannabis in Canada, and medical cannabis products in other legal global markets, primarily Portugal and the European Union. The firm operates in Flowr Canada segment. Flowr Canada segment is a licensed producer operating in Canada. The firm is focused on producing cannabis products for medical patients and recreational consumers across Canada, utilizing its indoor and outdoor cultivation and processing facilities located in the city of Kelowna in the Okanagan Valley Region of British Columbia, Canada (the Kelowna Campus). The Company’s brands include Flowr and FlowrRX. Flowr is a brand of cannabis produced in the Okanagan Valley.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
Over the last 5 months, Flowr Corp’s Operating Margin has increased from -213.3% to -171.4%. During this period, it reached a low of -213.3% on May 30, 2022 and a high of -171.4% on Oct 30, 2022.